East Brunswick, NJ, United States of America

William John Feaver

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Trovagene, Inc.. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William John Feaver. Retrieved from https://idiyas.com/inventor/william-john-feaver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • East Brunswick, NJ (US) (2015)
  • E Brunswick, NJ (US) (2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by William John Feaver

Introduction

William John Feaver is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of nucleic acid isolation and purification, holding a total of 2 patents.

Latest Patents

Feaver's latest patents focus on compositions, methods, and kits for isolating nucleic acids from body fluids using anion exchange media. The first patent provides compositions and methods for rapid separation, isolation, and purification of nucleic acids from biological samples. This method utilizes commercially available strong or weak anion exchanger materials with selected solutions of known ionic strength for adsorption and elution. It is particularly advantageous as it allows for the purification and identification of shorter fragments of nucleic acids from bodily fluids, which had not been identified until now. The second patent also addresses the rapid isolation and purification of nucleopolymers from biological samples using anionic exchange media. This method can utilize commercially available anion exchanger materials and allows for the storage or transport of the medium/nucleoprotein bound complex. The method is beneficial as it enables the rapid isolation and purification of soluble nucleic acids from large volumes of biological fluids, stabilizing the samples against degradation prior to analysis.

Career Highlights

William John Feaver is currently associated with Trovagene, Inc., where he continues to innovate in the field of molecular diagnostics. His work has significantly advanced the methodologies used in nucleic acid research and diagnostics.

Collaborations

Feaver has collaborated with notable coworkers such as Hovsep S Melkonyan and Erik Meyer, contributing to the advancement of their shared research goals.

Conclusion

William John Feaver's contributions to the field of nucleic acid isolation and purification have made a lasting impact on molecular diagnostics. His innovative methods and compositions continue to enhance the efficiency and effectiveness of biological sample analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…